Before the market opened, Iambic reported a third-quarter loss of $38.5 million, or $8.52 a share, compared with a loss of $21.5 million, or $5.24 a share, a year earlier. Total operating expenses rose 52% to $41.5 million, reflecting higher research and development costs and increased general and administrative expenses.
The quarter also included a $10.4 million non-cash charge related to a change in the fair value of convertible notes. Iambic said the notes converted into common stock immediately before the closing of its initial public offering.

Comments (0)
No comments yet. Be the first!